Total Revenue Increased 16% and Core Revenue* Grew 14% over the Prior-Year Period –– Total Written Premium increased 15% to $1.2 billion over the Prior-Year Period –– Net Income of $12.7 million ...
Many investors look at analyst price estimates to determine whether a stock is a buy, sell, or hold. But what if you could ...
Alkermes plc (Nasdaq: ALKS) ("Alkermes") and Avadel Pharmaceuticals plc (Nasdaq: AVDL) ("Avadel") today announced that the companies have entered into a definitive agreement under which Alkermes will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback